www.hiv-persistence.com
Open in
urlscan Pro
31.170.8.39
Public Scan
Submitted URL: http://stats.overcome.fr/c6.php?ec=2&l=h4KPu4Soi29sj5dr&i=ZGRpl2aXY21o&t=ZA&e=pqGf2HDGmaxgns6fldVgndQ&u=m6iq1KOdYGaqp9xgm...
Effective URL: https://www.hiv-persistence.com/about
Submission: On August 20 via api from FR — Scanned from FR
Effective URL: https://www.hiv-persistence.com/about
Submission: On August 20 via api from FR — Scanned from FR
Form analysis
1 forms found in the DOMPOST #sbscrbr-form
<form id="sbscrbr-form" method="post" action="#sbscrbr-form" class="subscrbr-sign-up-form">
<p class="sbscrbr-email-wrap">
<input type="text" name="sbscrbr_email" value="" placeholder="E-mail">
</p>
<p class="sbscrbr-unsubscribe-wrap">
<label>
<input id="sbscrbr-checkbox" type="checkbox" name="sbscrbr_unsubscribe" value="yes" style="vertical-align: middle;"> unsubscribe</label>
</p>
<p class="sbscrbr-submit-block" style="position: relative;">
<input type="submit" value="Subscribe" name="sbscrbr_submit_email" class="submit">
<input type="hidden" value="sbscrbr_shortcode_1" name="sbscrbr_form_id">
</p>
</form>
Text Content
Skip to content HIV Persistence during therapy International Workshop Miami * Home * Workshop Information * About * Press * Past editions * Committees * Program * PROGRAM SUMMARY * FINAL PROGRAM 2022 * Abstracts * Registration * GENERAL INFORMATION * Corporate support * Home * Workshop Information * About * Press * Past editions * Committees * Program * PROGRAM SUMMARY * FINAL PROGRAM 2022 * Abstracts * Registration * GENERAL INFORMATION * Corporate support December 2015 Three Hundred Scientists Meet in Miami to Work on a HIV Cure January 20, 2015 New anti HIV Drug Dolutegravir is Effective at Low Doses and in the Search for a HIV Cure 05 August 2014 General Hospital Reveals Fourteen Years of HIV Functional Cure: The Case of the ‘Toulon Patient’ 04 July 2014 New Approaches Towards HIV Cure to be Tested in Protocol Zero 29 June 2014 Seventh HIV Persistence Workshop: Researchers United Towards HIV Cure And Reservoirs Eradication ABOUT The International Workshop on HIV Persistence during Therapy is, historically, the first meeting centered on HIV reservoirs. In 2003, a group of researchers understood the need for a regular meeting focused on new findings from basic to clinical science on the persistence of HIV. HIV reservoirs were only described at the end of 1997 and it was clear that they were the main obstacles toward HIV eradication. At that time it was not a research priority and most groups were rather interested by the management of cART side effects. However, in 2005, during the second edition of the workshop, the first results of a clinical trial using HDAC inhibitors to reverse latency within the HIV reservoir were presented. In 2009, during the fourth edition, attendees were presented with a case of a Berlin patient who fuelled hope in the field of an HIV cure. Mechanisms of HIV persistence and new strategies toward HIV eradication became the high priority for research agencies and governments. Since its start, the HIV Persistence during Therapy Workshop has welcomed the main leaders in this challenging field who have shared their cutting edge work in oral or poster presentation form with the support of NIH, ANRS, and other organizations. Growing from 90 participants in 2003 to over 400 participants in 2022, it is recognized as the reference workshop on HIV reservoirs and cure by the scientific community. The members of the Steering and Scientific Committees are well renowned scientists publishing regularly in high impact journals. Over four days, the workshop covers basic to clinical science, virologic, immunologic and pharmacologic aspects of HIV persistence, and is attended by basic science researchers, virologists, immunologists and clinicians. Broad participation enables important exchanges between diverse workers in the field. The workshop seeks to involve others outside HIV research that contribute to future advances. The HIV Persistence during Therapy Workshop is dedicated to progress towards the end of the HIV pandemic. Newsletter unsubscribe By providing us with your email, you agree to receive the HIV Persistence newsletter and confirm that you have read and understood our privacy policy available here. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of our emails or by contacting us at rgpd@overcome.fr Organization 13-15 rue des Sablons 75116 Paris – France Phone:+33 (0)1 40 88 97 97, Email: hivpersistence@overcome.fr © 2018 - 2022 HIV Persistence. All Rights Reserved - Legal Information. Go to Top We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. Accept AllReject All Manage consent Close PRIVACY OVERVIEW This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the ... Necessary Necessary Always Enabled Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously. CookieDurationDescriptioncookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. Functional Functional Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. Performance Performance Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors. Analytics Analytics Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. Advertisement Advertisement Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads. Others Others Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet. SAVE & ACCEPT